RamA transcription factor mutant for promoting production of N-acetylglucosamine and use thereof
US12275763B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Jan 7, 2020 |
| Grant date | Apr 15, 2025 |
| Priority date | — |
| Expiry date | Dec 9, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/15
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention discloses a RamA transcription factor mutant for promoting the production of N-acetylglucosamine and use thereof. The mutant is obtained by mutating lysine at position 90 to asparagine and serine at position 92 to lysine in a parent having an amino acid sequence as shown in SEQ ID NO: 2. The present invention provides a genetically engineered strain that overexpresses the RamA transcription factor mutant and increases the production of N-acetylglucosamine. By overexpressing the transcription factor RamA that is involved in the regulation of carbon metabolism, the extracellular accumulation of N-acetylglucosamine is increased, with a maximum concentration reaching 31.5 g/L, which lays a foundation for further metabolic engineering of Corynebacterium glutamicum to produce glucosamine. The method for constructing recombinant Corynebacterium glutamicum of the invention is simple, and convenient in use, and thus has good application prospects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.